0
contact-banner

Ubrogepant

Ubrogepant

API0232712

Ubrogepant

Ubrogepant is a CGRP receptor antagonist used for migraine.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    1374248-77-7

  • Synonyms

    Ubrogepant; 1374248-77-7; Ubrelvy

  • CHEMBL ID

    CHEMBL2364638

  • Indications

  • Molecule Type

    Small molecule

  • Compound CID

    68748835

  • Molecular Weight (g/mol)

    549.5

  • Molecular Formula

    C29H26F3N5O3

  • InChI

    InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1

  • InChIKey

    DDOOFTLHJSMHLN-ZQHRPCGSSA-N

  • SMILES

    C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6

  • IUPAC Name

    (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide

  • Exact Mass (Da)

    549.19877419

  • Monoisotopic Mass (Da)

    549.19877419

OUR PRODUCTS